Arnuity ellipta and Dexilant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arnuity ellipta (fluticasone furoate) and Dexilant (dexlansoprazole). Common drug interactions include headache among females and pain in extremity among males.

The phase IV clinical study analyzes what interactions people have when they take Arnuity ellipta and Dexilant. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Arnuity ellipta?

Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 3,482 Arnuity ellipta users. Check the latest studies of Arnuity ellipta.

What is Dexilant?

Dexilant has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 57,103 Dexilant users. Check the latest studies of Dexilant.



On Jul, 26, 2026

39 people who take Arnuity ellipta and Dexilant together, and have interactions are studied.

Arnuity ellipta and Dexilant drug interactions.

What are the common drug interactions of Arnuity Ellipta and Dexilant, by gender? *:

female:

  1. Headache (pain in head)
  2. Pyrexia (fever)
  3. Dyspnoea (difficult or laboured respiration)
  4. Lung disorder (lung disease)
  5. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  6. Asthma
  7. Atelectasis (partial or complete collapse of the lung)
  8. Blindness
  9. Chest discomfort
  10. Cough

male:

  1. Pain in extremity
  2. Arthralgia (joint pain)
  3. Dizziness
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Insomnia (sleeplessness)
  6. Intestinal obstruction
  7. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  8. Muscular weakness (muscle weakness)
  9. Nervousness
  10. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)

What are the common drug interactions of Arnuity Ellipta and Dexilant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Lung disorder (lung disease)
  2. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  3. Asthma
  4. Atelectasis (partial or complete collapse of the lung)
  5. Blindness
  6. Chest discomfort
  7. Cough
  8. Diaphragmatic disorder
  9. Dyspnoea (difficult or laboured respiration)
  10. Eosinophilia (eosinophil count in the peripheral blood exceeds)

50-59:

  1. Breast cancer
  2. Cystitis (inflammation of the wall of the bladder)
  3. Fatigue (feeling of tiredness)
  4. Influenza
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Respiratory tract infection
  8. Sinusitis (inflammation of sinus)
  9. Chills (felling of cold)
  10. Headache (pain in head)

60+:

  1. Pain in extremity
  2. Decreased appetite
  3. Chest pain
  4. Death
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Dyspnoea (difficult or laboured respiration)
  7. Hypertension (high blood pressure)
  8. Insomnia (sleeplessness)
  9. Intestinal obstruction
  10. Nervousness

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 7 people, 17.95%
  2. Asthma: 5 people, 12.82%
  3. Multiple Myeloma (cancer of the plasma cells): 3 people, 7.69%
  4. Abdominal Pain: 3 people, 7.69%
  5. Stress And Anxiety: 2 people, 5.13%
  6. Primary Immunodeficiency Syndrome: 2 people, 5.13%
  7. Nausea (feeling of having an urge to vomit): 2 people, 5.13%
  8. Migraine (headache): 2 people, 5.13%
  9. Immune System Disorder: 2 people, 5.13%
  10. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Arnuity ellipta and Dexilant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arnuity ellipta and Dexilant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arnuity ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dexilant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arnuity ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dexilant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate and dexlansoprazole (the active ingredients of Arnuity ellipta and Dexilant, respectively), and Arnuity ellipta and Dexilant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: